JAKUB TOLAR to Graft vs Host Disease
This is a "connection" page, showing publications JAKUB TOLAR has written about Graft vs Host Disease.
Connection Strength
1.748
-
Mesenchymal stromal cells for graft-versus-host disease. Hum Gene Ther. 2011 Mar; 22(3):257-62.
Score: 0.229
-
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease. Blood. 2025 Oct 23; 146(17):2047-2062.
Score: 0.159
-
Deficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHD. Blood. 2025 Jun 12; 145(24):2813-2827.
Score: 0.155
-
Targeting cell-surface VISTA expression on allospecific na?ve T cells promotes tolerance. Blood. 2025 Apr 10; 145(15):1687-1700.
Score: 0.153
-
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia mice. Blood. 2024 05 23; 143(21):2201-2216.
Score: 0.144
-
Prevention of acute GVHD using an orthogonal IL-2/IL-2R? system to selectively expand regulatory T?cells in?vivo. Blood. 2023 03 16; 141(11):1337-1352.
Score: 0.133
-
Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. Blood. 2018 04 12; 131(15):1743-1754.
Score: 0.093
-
Preclinical Testing of Antihuman CD28 Fab' Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease. Transplantation. 2016 Dec; 100(12):2630-2639.
Score: 0.086
-
Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failure. Am J Hematol. 2015 Oct; 90(10):892-6.
Score: 0.079
-
GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells. Blood. 2015 Sep 24; 126(13):1621-8.
Score: 0.078
-
An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomes. Biol Blood Marrow Transplant. 2015 Jan; 21(1):81-8.
Score: 0.074
-
Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration. Blood. 2013 Sep 19; 122(12):2125-34.
Score: 0.068
-
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood. 2010 Dec 16; 116(25):5738-47.
Score: 0.056
-
Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells. Br J Haematol. 2009 Oct; 147(2):200-6.
Score: 0.052
-
Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming. Blood. 2009 Jul 16; 114(3):693-701.
Score: 0.051
-
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). Blood. 2007 Nov 01; 110(9):3480-8.
Score: 0.045
-
Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation. Transplant Cell Ther. 2024 10; 30(10):1005.e1-1005.e17.
Score: 0.036
-
Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita. Br J Haematol. 2018 10; 183(1):110-118.
Score: 0.024
-
Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres. Mol Genet Metab. 2016 Mar; 117(3):373-7.
Score: 0.020
-
Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood. 2011 Aug 18; 118(7):1971-8.
Score: 0.015